$BFST
Business First Bancshares Inc

2016 Q1 Form 10-Q Financial Statement

#000119312516591463 Filed on May 16, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 Q1
Revenue $10.71M $7.102M
YoY Change 50.83%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $320.0K
YoY Change
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $1.281M $936.0K
YoY Change 36.86%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $1.801M $1.563M
YoY Change 15.23%
Income Tax $397.0K $430.0K
% Of Pretax Income 22.04% 27.51%
Net Earnings $1.404M $1.133M
YoY Change 23.92%
Net Earnings / Revenue 13.11% 15.95%
Basic Earnings Per Share $0.20 $0.21
Diluted Earnings Per Share $0.19 $0.20
COMMON SHARES
Basic Shares Outstanding 7.037M 5.315M shares
Diluted Shares Outstanding 7.325M 5.609M shares

Balance Sheet

Concept 2016 Q1 2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $73.35M $31.48M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $9.176M
YoY Change
Goodwill $6.824M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.156B
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $600.0K
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $3.000M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $600.0K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $7.800M
YoY Change
Total Long-Term Liabilities $7.800M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $600.0K
Total Long-Term Liabilities $7.800M
Total Liabilities $1.041B
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings $21.69M
YoY Change
Common Stock $93.07M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $115.0M $80.52M
YoY Change
Total Liabilities & Shareholders Equity $1.156B
YoY Change

Cashflow Statement

Concept 2016 Q1 2015 Q1
OPERATING ACTIVITIES
Net Income $1.404M $1.133M
YoY Change 23.92%
Depreciation, Depletion And Amortization $320.0K
YoY Change
Cash From Operating Activities $2.507M $2.129M
YoY Change 17.75%
INVESTING ACTIVITIES
Capital Expenditures $261.0K $72.00K
YoY Change 262.5%
Acquisitions
YoY Change
Other Investing Activities -$43.99M
YoY Change
Cash From Investing Activities -$44.25M -$45.06M
YoY Change -1.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 74.18M 48.39M
YoY Change 53.29%
NET CHANGE
Cash From Operating Activities 2.507M 2.129M
Cash From Investing Activities -44.25M -45.06M
Cash From Financing Activities 74.18M 48.39M
Net Change In Cash 32.44M 5.468M
YoY Change 493.23%
FREE CASH FLOW
Cash From Operating Activities $2.507M $2.129M
Capital Expenditures $261.0K $72.00K
Free Cash Flow $2.246M $2.057M
YoY Change 9.19%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
773123000
CY2016Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1358000
CY2016Q1 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
48628000
CY2016Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
609000
CY2016Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
21693000
CY2016Q1 us-gaap Liabilities
Liabilities
1041207000
CY2016Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1156201000
CY2016Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7037413 shares
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
80523000
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31483000
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000 shares
CY2016Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7037413 shares
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7037413 shares
CY2016Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
86033000
CY2016Q1 us-gaap Stockholders Equity
StockholdersEquity
114994000
CY2016Q1 us-gaap Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Allowance For Loan Losses
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAllowanceForLoanLosses
98000
CY2016Q1 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
205185000
CY2016Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
6478000
CY2016Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
3000000
CY2016Q1 us-gaap Other Liabilities
OtherLiabilities
7797000
CY2016Q1 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
776000
CY2016Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
638000
CY2016Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
7214000
CY2016Q1 us-gaap Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
0
CY2016Q1 us-gaap Common Stock Value
CommonStockValue
7037000
CY2016Q1 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
638000
CY2016Q1 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
2865000
CY2016Q1 us-gaap Liabilities Fair Value Disclosure Nonrecurring
LiabilitiesFairValueDisclosureNonrecurring
0
CY2016Q1 us-gaap Deposits
Deposits
978308000
CY2016Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
231000
CY2016Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
206920000
CY2016Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
773670000
CY2016Q1 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
16328000
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
206920000
CY2016Q1 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
11358000
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
100280000
CY2016Q1 us-gaap Assets
Assets
1156201000
CY2016Q1 us-gaap Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Carrying Amount Net
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesCarryingAmountNet
2723000
CY2016Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1008000
CY2016Q1 us-gaap Cash And Due From Banks
CashAndDueFromBanks
73349000
CY2016Q1 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
1844000
CY2016Q1 us-gaap Interest Receivable
InterestReceivable
2710000
CY2016Q1 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
14484000
CY2016Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
77457000
CY2016Q1 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
782165000
CY2016Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9176000
CY2016Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
104580000
CY2016Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
369000
CY2016Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
12986000
CY2016Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
1008000
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
56640000
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
2461000
CY2016Q1 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
786124000
CY2016Q1 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
1628000
CY2016Q1 us-gaap Other Assets
OtherAssets
8069000
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
47238000
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
100678000
CY2016Q1 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
12986000
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
46805000
CY2016Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
27123000
CY2016Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2486000
CY2016Q1 us-gaap Goodwill
Goodwill
6824000
CY2016Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
639000
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
56941000
CY2016Q1 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
22132000
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
73349000
CY2016Q1 us-gaap Federal Funds Sold
FederalFundsSold
34521000
CY2016Q1 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
789379000
CY2016Q1 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
3255000
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
206570000
CY2016Q1 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
41000
CY2016Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
206570000
CY2016Q1 us-gaap Assets Fair Value Disclosure Nonrecurring
AssetsFairValueDisclosureNonrecurring
17414000
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
2447000
CY2016Q1 ck0001624322 Loans Receivable Unpaid Principal Balance
LoansReceivableUnpaidPrincipalBalance
45700000
CY2016Q1 ck0001624322 Other Equity Securities
OtherEquitySecurities
5408000
CY2016Q1 ck0001624322 Other Real Estate Owned
OtherRealEstateOwned
2441000
CY2016Q1 ck0001624322 Loans And Leases Receivable Reclassified From Overdraft
LoansAndLeasesReceivableReclassifiedFromOverdraft
134000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
78845000
CY2014Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
6632000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26015000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7035913 shares
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7035913 shares
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
85913000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
112449000
CY2015Q4 us-gaap Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Allowance For Loan Losses
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAllowanceForLoanLosses
98000
CY2015Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
222488000
CY2015Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
6038000
CY2015Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
3000000
CY2015Q4 us-gaap Other Liabilities
OtherLiabilities
4259000
CY2015Q4 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
740000
CY2015Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
1108000
CY2015Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
7244000
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
956000
CY2015Q4 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
49144000
CY2015Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
566000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
20289000
CY2015Q4 us-gaap Liabilities
Liabilities
963640000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1076089000
CY2015Q4 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
681748000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
7036000
CY2015Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
1108000
CY2015Q4 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
2435000
CY2015Q4 us-gaap Deposits
Deposits
904236000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-789000
CY2015Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
210857000
CY2015Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
756962000
CY2015Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
14622000
CY2015Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
9180000
CY2015Q4 us-gaap Assets
Assets
1076089000
CY2015Q4 us-gaap Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Carrying Amount Net
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesCarryingAmountNet
3634000
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2152000
CY2015Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
40911000
CY2015Q4 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
3480000
CY2015Q4 us-gaap Interest Receivable
InterestReceivable
2823000
CY2015Q4 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
11142000
CY2015Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
125279000
CY2015Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
765148000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9234000
CY2015Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
151770000
CY2015Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
1209000
CY2015Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
11796000
CY2015Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
2152000
CY2015Q4 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
768728000
CY2015Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
2616000
CY2015Q4 us-gaap Other Assets
OtherAssets
8967000
CY2015Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
11796000
CY2015Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
26491000
CY2015Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2555000
CY2015Q4 us-gaap Goodwill
Goodwill
3376000
CY2015Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
943000
CY2015Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
22339000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
40911000
CY2015Q4 us-gaap Federal Funds Sold
FederalFundsSold
2496000
CY2015Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
772392000
CY2015Q4 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
3664000
CY2015Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
212053000
CY2015Q4 us-gaap Assets Fair Value Disclosure Nonrecurring
AssetsFairValueDisclosureNonrecurring
16257000
CY2015Q4 ck0001624322 Loans Receivable Unpaid Principal Balance
LoansReceivableUnpaidPrincipalBalance
44700000
CY2015Q4 ck0001624322 Other Equity Securities
OtherEquitySecurities
5350000
CY2015Q4 ck0001624322 Other Real Estate Owned
OtherRealEstateOwned
2033000
CY2015Q4 ck0001624322 Loans And Leases Receivable Reclassified From Overdraft
LoansAndLeasesReceivableReclassifiedFromOverdraft
150000
CY2015 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
11 Contracts
CY2015 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
397000
CY2015 us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
5865000
CY2015 us-gaap Financing Receivable Modifications Subsequent Default Recorded Investment1
FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1
54000000
CY2015 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
1200000
CY2015 us-gaap Financing Receivable Modifications Pre Modification Recorded Investment2
FinancingReceivableModificationsPreModificationRecordedInvestment2
8447000
CY2015 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
985000
CY2015 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
13285000
CY2015 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
10907000
CY2015 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
2378000
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
CY2015Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
293600 shares
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2129000
CY2015Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5608525 shares
CY2015Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5314925 shares
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
72000
CY2015Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-81000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
1133000
CY2015Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
642000
CY2015Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
424000
CY2015Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
21151000
CY2015Q1 us-gaap Interest Paid
InterestPaid
86000
CY2015Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
6633000
CY2015Q1 us-gaap Available For Sale Securities Change In Net Unrealized Holding Gain Loss
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss
643000
CY2015Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
121000
CY2015Q1 us-gaap Profit Loss
ProfitLoss
1133000
CY2015Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
6166000
CY2015Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-221000
CY2015Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
250000
CY2015Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-87000
CY2015Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
15820000
CY2015Q1 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
137000
CY2015Q1 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
146000
CY2015Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
7102000
CY2015Q1 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
22000
CY2015Q1 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
1894000
CY2015Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
6016000
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1563000
CY2015Q1 us-gaap Fees And Commissions Depositor Accounts
FeesAndCommissionsDepositorAccounts
149000
CY2015Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
280000
CY2015Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1557000
CY2015Q1 us-gaap Noninterest Income
NoninterestIncome
429000
CY2015Q1 us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
443000
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
430000
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
121000
CY2015Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
218000
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
5468000
CY2015Q1 us-gaap Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
93000
CY2015Q1 us-gaap Interest Expense
InterestExpense
936000
CY2015Q1 us-gaap Increase Decrease In Federal Funds Sold
IncreaseDecreaseInFederalFundsSold
-7662000
CY2015Q1 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
86000
CY2015Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
1287000
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
48394000
CY2015Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
338000
CY2015Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
150000
CY2015Q1 us-gaap Occupancy Net
OccupancyNet
657000
CY2015Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2938000
CY2015Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-15000
CY2015Q1 us-gaap Noninterest Expense
NoninterestExpense
4882000
CY2015Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
202000
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-45055000
CY2015Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
38394000
CY2015Q1 us-gaap Available For Sale Securities Income Tax Expense On Change In Unrealized Holding Gain Or Loss
AvailableForSaleSecuritiesIncomeTaxExpenseOnChangeInUnrealizedHoldingGainOrLoss
-219000
CY2015Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-30000
CY2015Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
850000
CY2015Q1 ck0001624322 Interest On Deposits
InterestOnDeposits
865000
CY2015Q1 ck0001624322 Proceeds From Repayments Of Federal Home Loan Bank Advances
ProceedsFromRepaymentsOfFederalHomeLoanBankAdvances
10000000
CY2015Q1 ck0001624322 Proceeds From Repayments Of Investment Securities Available For Sale
ProceedsFromRepaymentsOfInvestmentSecuritiesAvailableForSale
1451000
CY2015Q1 ck0001624322 Interest On Federal Funds Sold And Due From Banks
InterestOnFederalFundsSoldAndDueFromBanks
26000
CY2016Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2016Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016Q1 dei Amendment Flag
AmendmentFlag
false
CY2016Q1 dei Document Type
DocumentType
10-Q
CY2016Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001624322
CY2016Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2016Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
288357 shares
CY2016Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2507000
CY2016Q1 dei Entity Registrant Name
EntityRegistrantName
BUSINESS FIRST BANCSHARES, INC.
CY2016Q1 us-gaap Reclassifications
Reclassifications
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Note 2 &#x2013; Reclassifications &#x2013;</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 6pt"> Certain reclassifications may have been made to conform to the classifications adopted for reporting in 2016. These reclassifications have no effect on previously reported net income.</p> </div>
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7325358 shares
CY2016Q1 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
12 Contracts
CY2016Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7037001 shares
CY2016Q1 dei Document Period End Date
DocumentPeriodEndDate
2016-03-31
CY2016Q1 us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Note 8 &#x2013; Litigation &#x2013;</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 6pt"> In conjunction with the AGFC merger, certain shareholders exercised their statutory rights of appraisal. As of March&#xA0;31, 2016, there were 53,094 unsettled AGFC shares, with the fair value amount per AGFC share in dispute. This litigation is ongoing, with a trial date set for late May 2016. In June 2015, the Company made a cash payment of $155 per AGFC share to the unsettled former AGFC shareholders, representing the amount the Company estimated to be the fair value of the former AGFC shareholders&#x2019; AGFC shares. A group of former AGFC shareholders are disputing the Company&#x2019;s determination of fair value, and have requested a cash merger consideration payment of $263 per AGFC share. As calculated in accordance with the merger agreement, the AGFC merger consideration to the former AGFC shareholders was valued at $219.94 per AGFC share, with $10 paid in cash and the remainder in shares of the Company&#x2019;s common stock. The AGFC purchase price reflected in these financial statements includes the Company&#x2019;s estimate of the maximum additional cash consideration which could be payable to the unsettled former AGFC shareholders upon settlement of the ongoing litigation. This estimate is based upon the $219.94 value per AGFC share as calculated in accordance with the merger agreement, less amounts already paid to said shareholders and totals $3.45 million, and is reflected in Other Liabilities as of March&#xA0;31, 2016. The amount of the ultimate settlement is unknown as of the date of these financial statements. Any legal costs associated with defense of this litigation are being expensed as incurred.</p> </div>
CY2016Q1 dei Trading Symbol
TradingSymbol
ck0001624322
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
261000
CY2016Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-113000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
1404000
CY2016Q1 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
15000
CY2016Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
1370000
CY2016Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1020000
CY2016Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
17598000
CY2016Q1 us-gaap Interest Paid
InterestPaid
196000
CY2016Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
9697000
CY2016Q1 us-gaap Available For Sale Securities Change In Net Unrealized Holding Gain Loss
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss
1545000
CY2016Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
106000
CY2016Q1 us-gaap Profit Loss
ProfitLoss
1404000
CY2016Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
9431000
CY2016Q1 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
46000
CY2016Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-267000
CY2016Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-459000
CY2016Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
11992000
CY2016Q1 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
353000
CY2016Q1 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
77000
CY2016Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
10712000
CY2016Q1 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
-26000
CY2016Q1 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
175000
CY2016Q1 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
60000
CY2016Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
8761000
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1801000
CY2016Q1 us-gaap Fees And Commissions Depositor Accounts
FeesAndCommissionsDepositorAccounts
494000
CY2016Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
772000
CY2016Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2424000
CY2016Q1 us-gaap Noninterest Income
NoninterestIncome
1441000
CY2016Q1 us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
974000
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
397000
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
106000
CY2016Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
525000
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
32438000
CY2016Q1 us-gaap Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
33000
CY2016Q1 us-gaap Interest Expense
InterestExpense
1281000
CY2016Q1 us-gaap Increase Decrease In Federal Funds Sold
IncreaseDecreaseInFederalFundsSold
-32025000
CY2016Q1 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
174000
CY2016Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
2602000
CY2016Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
15000
CY2016Q1 us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
7301000
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
74184000
CY2016Q1 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
365000
CY2016Q1 us-gaap Financing Receivable Modifications Subsequent Default Recorded Investment1
FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1
0
CY2016Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
90000
CY2016Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
670000
CY2016Q1 us-gaap Financing Receivable Modifications Pre Modification Recorded Investment2
FinancingReceivableModificationsPreModificationRecordedInvestment2
10005000
CY2016Q1 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
746000
CY2016Q1 us-gaap Occupancy Net
OccupancyNet
1103000
CY2016Q1 us-gaap Proceeds From Payments For In Securities Sold Under Agreements To Repurchase
ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase
430000
CY2016Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
12035000
CY2016Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
4696000
CY2016Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
43000
CY2016Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
-175000
CY2016Q1 us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
560000
CY2016Q1 us-gaap Noninterest Expense
NoninterestExpense
8401000
CY2016Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
319000
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-44253000
CY2016Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
74072000
CY2016Q1 us-gaap Available For Sale Securities Income Tax Expense On Change In Unrealized Holding Gain Or Loss
AvailableForSaleSecuritiesIncomeTaxExpenseOnChangeInUnrealizedHoldingGainOrLoss
-525000
CY2016Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
106000
CY2016Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
1107000
CY2016Q1 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
11974000
CY2016Q1 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
9312000
CY2016Q1 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
2662000
CY2016Q1 ck0001624322 Number Of Banking Centers
NumberOfBankingCenters
16
CY2016Q1 ck0001624322 Number Of Loan Production Office
NumberOfLoanProductionOffice
1 Office
CY2016Q1 ck0001624322 Interest On Deposits
InterestOnDeposits
1042000
CY2016Q1 ck0001624322 Proceeds From Repayments Of Federal Home Loan Bank Advances
ProceedsFromRepaymentsOfFederalHomeLoanBankAdvances
-333000
CY2016Q1 ck0001624322 Proceeds From Repayments Of Investment Securities Available For Sale
ProceedsFromRepaymentsOfInvestmentSecuritiesAvailableForSale
5155000
CY2016Q1 ck0001624322 Business Acquisition Amortization Accretion Fair Market Value Adjustments
BusinessAcquisitionAmortizationAccretionFairMarketValueAdjustments
-568000
CY2016Q1 ck0001624322 Interest On Federal Funds Sold And Due From Banks
InterestOnFederalFundsSoldAndDueFromBanks
41000
CY2016Q1 ck0001624322 Redemption Of Other Equity Securities
RedemptionOfOtherEquitySecurities
2000
CY2016Q1 ck0001624322 Improvements To Other Real Estate
ImprovementsToOtherRealEstate
102000
CY2016Q1 ck0001624322 Number Of Wealth Solutions Office
NumberOfWealthSolutionsOffice
1 Office

Files In Submission

Name View Source Status
0001193125-16-591463-index-headers.html Edgar Link pending
0001193125-16-591463-index.html Edgar Link pending
0001193125-16-591463.txt Edgar Link pending
0001193125-16-591463-xbrl.zip Edgar Link pending
ck0001624322-20160331.xml Edgar Link completed
ck0001624322-20160331.xsd Edgar Link pending
ck0001624322-20160331_cal.xml Edgar Link unprocessable
ck0001624322-20160331_def.xml Edgar Link unprocessable
ck0001624322-20160331_lab.xml Edgar Link unprocessable
ck0001624322-20160331_pre.xml Edgar Link unprocessable
d159473d10q.htm Edgar Link pending
d159473dex311.htm Edgar Link pending
d159473dex312.htm Edgar Link pending
d159473dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending